Shuang Hao

Shuang Hao

Health Economist
Visiting address: ,
Postal address: C8 Medicinsk epidemiologi och biostatistik, C8 MEB II Clements, 171 77 Stockholm
Part of:

About me

  • Health economist at MEB, KI. Also attached to the Health Economics and Policy Research Group at LIME (https://ki.se/en/lime/health-economics-and-policy-research-group).

    I am a health economist at MEB working in the research group led by Mark Clements [1] and the prostate cancer research group at MEB. My projects mainly focus on the economic evaluations of cancer screening, diagnosis and disease management, particularly for prostate cancer and breast cancer in Sweden. I also worked as a consultant (20%) at Stockholm Centre for Health Economics (StoCHE [2]) under Region Stockholm. In addition, I am the coordinator of the working group Health Economics for the Swedish Consortium for Research on Organised Prostate Cancer Testing (OPT). I also support the regional OPT team and the Regional Cancer Center in Stockholm.

    I have been in collaboration with researchers from the German Cancer Research Centre (DKFZ) and University of Zurich for modelling prostate cancer screening and assessing cost-effectiveness of the screening programs.

    I defended my thesis titled Prostate cancer testing in Sweden: the interplay between cost and effectiveness [3] in early December, 2022 (see also publications between 2020 and 2022). The PhD programme was supervised by Mark Clements (principal) [4], Emelie Heintz [5], Martin Eklund [6] and Ellinor Östensson [7].

    Prior to the PhD programme, I had 9-year working experiences in the consulting and pharmaceutical industries.

    Education background: PhD Health Economics
  • MPH Health Economics
  • MSc Applied Economics
  • BSc Statistics

    [1] https://staff.ki.se/people/marcle
    [2] https://www.slso.regionstockholm.se/forskning-och-utveckling/centrum-for-halsoekonomi-informatik-och-sjukvardsforskning/
    [3] https://openarchive.ki.se/xmlui/handle/10616/48198
    [4] https://staff.ki.se/people/marcle
    [5] https://staff.ki.se/people/emelhe
    [6] https://staff.ki.se/people/maeklu
    [7] https://medarbetare.ki.se/people/ellham

Research

  • Publication
    Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study [1]
    *Hao S*, Discacciati A, Eklund M, et al. Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study [published online ahead of print, 2022 Nov 10]. /JAMA Oncol/. 2022
  • 9(1):88-94. doi:10.1001/jamaoncol.2022.5252

    Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study [2]
    *Hao S*, Heintz E, Östensson E, et al. Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study [published correction appears in Eur Urol. 2022 Mar 30]. /Eur Urol/. 2022
  • 82(1):12-19. doi:10.1016/j.eururo.2021.12.021

    Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study [3]
    *Hao S*, Karlsson A, Heintz E, Elfström KM, Nordström T, Clements M. Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study. /Value Health/. 2021
  • 24(12):1763-1772. doi:10.1016/j.jval.2021.06.001

    The cost-effectiveness of prostate cancer screening using the Stockholm3 test [4]
    Karlsson AA, *Hao S*, Jauhiainen A, et al. The cost-effectiveness of prostate cancer screening using the Stockholm3 test. /PLoS One/. 2021
  • 16(2):e0246674. Published 2021 Feb 25. doi:10.1371/journal.pone.0246674

    The economic burden of prostate cancer - a Swedish prevalence-based register study [5]
    *Hao S*, Östensson E, Eklund M, et al. The economic burden of prostate cancer - a Swedish prevalence-based register study. /BMC Health Serv Res/. 2020
  • 20(1):448. Published 2020 May 20. doi:10.1186/s12913-020-05265-8

    Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China [6]
    *Hao S*, Heintz E, Helgesson G, Langenskiöld S, Chen J, Burström K. Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China. /Qual Life Res/. 2020
  • 29(1):289-301. doi:10.1007/s11136-019-02292-9

    Report
    Kostnadseffektiviteten av bältrosvaccinering med Shingrix® i Region Stockholm [7]
    Nystrand C, *Hao S*, Heintz E, Sparring V. Kostnadseffektiviteten av bältrosvaccinering med Shingrix® i Region Stockholm. Stockholm centrum för hälsoekonomi. Centrum för hälsoekonomi, informatik och sjukvårdsforskning, Region Stockholm, 2023. Rapport 2023:2

    Hälsoekonomiska konsekvenser av en utvidgad egenprovtagning för klamydia och gonorré i Region Stockholm: Del 2 – analys av kostnadseffektivitet med en dynamisk epidemiologisk modell. [8]
    Stockholm centrum för hälsoekonomi, Centrum för hälsoekonomi, informatik och sjukvårdsforskning, Region Stockholm
  • 2023. Rapport 2023:5


    [1] https://jamanetwork.com/journals/jamaoncology/fullarticle/2798261
    [2] https://www.europeanurology.com/article/S0302-2838(21)02269-7/fulltext
    [3] https://www.valueinhealthjournal.com/article/S1098-3015(21)01587-4/fulltext
    [4] https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0246674
    [5] https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05265-8
    [6] https://www.google.com/search?q=10.1007%2Fs11136-019-02292-9&
  • amp
  • oq=10.1007%2Fs11136-019-02292-9&
  • amp
  • aqs=chrome..69i57j69i60l3.770j0j9&
  • amp
  • sourceid=chrome&
  • amp
  • ie=UTF-8
    [7] https://www.chis.regionstockholm.se/StoCHE/rapporter/
    https://www.chis.regionstockholm.se/49d8c5/globalassets/verksamheter/chis/stoche/rapport_baltrosvaccinering.pdf
    [8] https://www.chis.regionstockholm.se/StoCHE/rapporter/
    https://www.chis.regionstockholm.se/48dbe1/globalassets/verksamheter/chis/stoche/halsoekonomiska-konsekvenser-av-en-utvidgad-egenprovtagning-for-klamydia-och-gonorre-i-region-stockholm---del-2-2.pdf

Teaching

  • 3196 Global Health Economics [1]
    [1] https://kiwas.ki.se/katalog/kursplan/show/4499?lang=en

Articles

All other publications

Employments

  • Health Economist, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2022-

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2023
  • Degree Of Master Of Medical Science 120 Credits, Karolinska Institutet, 2016

Supervisor

  • Enoch Chen, Extrapolating survival with applications in health technology assessment, 2021

News from KI

Events from KI